首页> 外文期刊>Biotechnology healthcare >Rethinking Comparative Effectiveness Research: An Interview With Dr. Donald Berwick, President and CEO, Institute for Healthcare Improvement
【24h】

Rethinking Comparative Effectiveness Research: An Interview With Dr. Donald Berwick, President and CEO, Institute for Healthcare Improvement

机译:反思比较有效性研究:医疗改善研究所所长兼首席执行官唐纳德·贝里克博士的访谈

获取原文
获取原文并翻译 | 示例
       

摘要

Comparative effectiveness research on a national basis is now a reality. In March, the United States Department of Health and Human Services, one of three government agencies that received CER funds under the American Recovery and Reinvestment Act of 2009 - the other two were the National Institutes of Health and the Agency for Healthcare Research and Quality - named the 15 members of the new Federal Coordinating Council for Comparative Effectiveness Research. The Council is already holding public listening sessions on how to use CER to reduce ineffective and costly medical treatments.
机译:现在,在全国范围内进行比较有效性研究已经成为现实。 3月,美国卫生与公共服务部是根据2009年《美国复苏与再投资法案》获得CER资金的三个政府机构之一-其他两个是美国国立卫生研究院和医疗保健研究与质量机构-任命了新的比较效能研究联邦协调委员会的15名成员。理事会已经就如何使用CER减少无效和昂贵的医疗服务举行公开听证会。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号